# AccessBio signs ₩22B COVID-19 antigen test kit supply contract with Intrivo Diagnostics

AccessBio signed a contract with Intrivo Diagnostics to supply COVID-19 antigen test kits for the US market. The contract value is ₩22 billion.

- Type: Contract
- Announced: 2021-10-08
- Where: United States
- Value: $18.5M (22.0B KRW)
- Status: announced
- Products: COVID-19 antigen test kits
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [AccessBio](https://endata.com/companies/58272.md) (supplier)
- [Intrivo Diagnostics](https://endata.com/companies/58273.md) (customer)

## Sources

- [fnnews.com](https://www.fnnews.com/news/202110081146403166), 2021-10-08: "엑세스바이오는 의료기기 유통업체 Intrivo Diagnostics와 COVID-19 항원진단키트 공급계약을 체결했다고 8일 공시했다."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.